Halaman 4 - Kanker kandung kemih Dokter Terbaik - TOP-117 dokter

Dr. Ozden berspesialisasi dalam pengobatan kanker kandung kemih dengan pelatihan ekstensif di bidang onkologi medis di Fakultas Kedokteran Universitas Kocaeli.

• Pengalaman lebih dari 20 tahun di bidang penyakit dalam dan onkologi
• Menempuh pendidikan di Universitas Istanbul, salah satu sekolah kedokteran ternama di Turki
• Ahli dalam protokol kemoterapi dan imunoterapi untuk kanker kandung kemih

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.

He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.

Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).

Kepala Departemen Urologi Samsung – Dr. Choi Han Yong spesialis dalam perawatan kanker kandung kemih di Samsung Medical Center.

• Onkosurgeri dengan fokus pada kanker urologi
• Memimpin departemen urologi tingkat atas
• Berpengalaman dalam prosedur kanker kandung kemih tingkat lanjut

Michael Van Kampen adalah spesialis radioterapi yang berdedikasi dengan pengalaman luas dalam mengobati kanker urologi seperti kanker kandung kemih.

• Pengalaman bertahun-tahun dalam praktik klinis terfokus di bidang onkologi radiasi
• Menerapkan teknik radioterapi terarget untuk mengobati sel-sel kanker
• Bekerja di Klinik Nordwest khusus di Frankfurt
• Bagian dari tim multidisiplin untuk perawatan kanker yang komprehensif

Prof. Dr. Eduard Becht membawa 41 tahun pengalaman urologi dan gelar doktor kehormatan dalam pekerjaannya di Klinik Nordwest. Keahliannya mencakup perawatan invasif minimal hingga bedah kompleks yang mempertahankan organ.

• Spesialisasi dalam uro-onkologi dan urologi rekonstruktif
• Menerima gelar doktor kehormatan dari Universitas Kapodistrias Athena
• Ketua asosiasi Uroonkologi Interdisipliner Frankfurt
• Menerbitkan lebih dari 100 karya ilmiah tentang kondisi urologi
• Menjadi dosen di Universitas Goethe di Frankfurt sejak 1994

Urologist, Surgeon

Dr. Yurdakul mengkhususkan diri dalam uro-onkologi dengan pelatihan lanjutan dari Cleveland Clinic Ohio dan University of Pittsburgh, dengan fokus pada perawatan kanker kandung kemih.

• Pengalaman lebih dari 17 tahun di bidang urologi dan uro-onkologi
• Menerbitkan 16 artikel ilmiah internasional dan 58 nasional
• Terlatih dalam bedah mikrovaskular di Mercy University
• Pembicara dan ketua sesi di pertemuan urologi nasional

Dr. Amiel adalah Kepala Departemen Urologi di Rambam Medical Center, yang berfokus pada bedah kanker. Perannya menunjukkan keahlian mendalam dalam kasus-kasus urologi yang kompleks.

• Spesialisasi sebagai ahli bedah onkologi untuk kanker sistem urin
• Memberikan perawatan di rumah sakit universitas besar di Israel

dr. Yutkin memiliki lebih dari 20 tahun pengalaman dalam diagnosis dan pengobatan di Hadassah Medical Center.

• Lulus dari Fakultas Kedokteran Hebrew University of Jerusalem
• Spesialisasi dalam gangguan sendi temporomandibular
• Lancar berbahasa Inggris, Ibrani, dan Rusia

Profesor Gofrit memiliki sertifikasi untuk melakukan bedah robotik untuk kanker urologi. Ia memimpin Departemen Urologi di Hadassah Medical Center.

• Menyelesaikan pelatihan onkologi urologi khusus di Chicago, AS
• Meneliti dan mengobati kanker kandung kemih dan ginjal secara khusus
• Mengajar bedah urologi di Hebrew University
• Memegang penghargaan nasional dan internasional atas karyanya di bidang urologi
• Spesialisasi dalam bedah endoskopi dan bantuan robot da Vinci

Prof. Jablonski-Perec menempuh pelatihan di Sloan-Kettering Cancer Center – salah satu institusi onkologi terkemuka di dunia – dan mengepalai Institut Onkologi di Hadassah Medical Center.

• Memimpin Pusat Perawatan Kanker Payudara sejak 1998
• Profesor Onkologi di Hebrew University
• Anggota dari beberapa komunitas kanker internasional
• Menerima beasiswa dari Hadassah Medical School

Ahli radioterapi yang berspesialisasi dalam pengobatan kanker kandung kemih di Assuta Medical Center.

• Spesialisasi dalam terapi radiasi
• Memiliki pengalaman mengobati berbagai kondisi onkologi
• Mempraktikkan pendekatan pengobatan berbasis bukti

Spesialis onkourologi – berfokus secara eksklusif pada kanker kandung kemih di Assuta Medical Center.

• Ahli urologi dengan keahlian mendalam dalam pengobatan kanker kandung kemih
• Bekerja di Assuta Medical Center – fasilitas onkologi terkemuka
• Berdedikasi pada onkourologi, memastikan perawatan khusus